GOOG
55
5
NFLX
62
4
FCX
39
5
PWR
49
2
REGN
36
-4
HSY
50
-6
MO
69
-2
DVA
65
-3
MAT
43
-3
ABT
60
-5
IFF
41
-3
GLW
46
2
XOM
56
2
HSIC
53
-6
CB
50
-5
K
59
2
MCK
74
-4
PHM
43
-5
WFC
68
7
AAP
20
3
GOOG
55
5
NFLX
62
4
FCX
39
5
PWR
49
2
REGN
36
-4
HSY
50
-6
MO
69
-2
DVA
65
-3
MAT
43
-3
ABT
60
-5
IFF
41
-3
GLW
46
2
XOM
56
2
HSIC
53
-6
CB
50
-5
K
59
2
MCK
74
-4
PHM
43
-5
WFC
68
7
AAP
20
3
Financhill
Back

Catalyst Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
75

CPRX
Catalyst Pharmaceuticals

Last Price:
$20.85
Seasonality Move:
10.33%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Buy
75
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.20. The Score for CPRX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 43.89 Sell
Chaikin Money Flow: 222623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.47 - 23.07) Sell
Bollinger Bands (100): (21.13 - 22.81) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.87 Sell
20-day SMA: 22.09 Sell
50-day SMA: 22.2 Sell
200-day SMA: 19.92 Buy
8-day EMA: 21.61 Sell
20-day EMA: 21.96 Sell
50-day EMA: 22.07 Sell
200-day EMA: 20.2 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.08 per share, and an increase next year of $0.24 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):